These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 9169612)

  • 1. Characterization of the human multidrug resistance protein containing mutations in the ATP-binding cassette signature region.
    Bakos E; Klein I; Welker E; Szabó K; Müller M; Sarkadi B; Váradi A
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):777-83. PubMed ID: 9169612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation site mutations in the human multidrug transporter modulate its drug-stimulated ATPase activity.
    Szabó K; Bakos E; Welker E; Müller M; Goodfellow HR; Higgins CF; Váradi A; Sarkadi B
    J Biol Chem; 1997 Sep; 272(37):23165-71. PubMed ID: 9287320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of glycine-534 and glycine-1179 of human multidrug resistance protein (MDR1) in drug-mediated control of ATP hydrolysis.
    Szakács G; Ozvegy C; Bakos E; Sarkadi B; Váradi A
    Biochem J; 2001 May; 356(Pt 1):71-5. PubMed ID: 11336637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered drug-stimulated ATPase activity in mutants of the human multidrug resistance protein.
    Müller M; Bakos E; Welker E; Váradi A; Germann UA; Gottesman MM; Morse BS; Roninson IB; Sarkadi B
    J Biol Chem; 1996 Jan; 271(4):1877-83. PubMed ID: 8567633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.
    Ramachandra M; Ambudkar SV; Gottesman MM; Pastan I; Hrycyna CA
    Mol Biol Cell; 1996 Oct; 7(10):1485-98. PubMed ID: 8898356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of human MDR1-MDR2 chimeras demonstrate the functional exchangeability of a major transmembrane segment of the multidrug transporter and phosphatidylcholine flippase.
    Zhou Y; Gottesman MM; Pastan I
    Mol Cell Biol; 1999 Feb; 19(2):1450-9. PubMed ID: 9891078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional asymmetry of the two nucleotide binding domains in the ABC transporter Ste6.
    Proff C; Kölling R
    Mol Gen Genet; 2001 Feb; 264(6):883-93. PubMed ID: 11254136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein.
    Hafkemeyer P; Dey S; Ambudkar SV; Hrycyna CA; Pastan I; Gottesman MM
    Biochemistry; 1998 Nov; 37(46):16400-9. PubMed ID: 9819232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of conserved carboxylate residues in the nucleotide binding sites of P-glycoprotein.
    Urbatsch IL; Julien M; Carrier I; Rousseau ME; Cayrol R; Gros P
    Biochemistry; 2000 Nov; 39(46):14138-49. PubMed ID: 11087362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the amino-terminal regions in the human multidrug resistance protein (MRP1).
    Bakos E; Evers R; Calenda G; Tusnády GE; Szakács G; Váradi A; Sarkadi B
    J Cell Sci; 2000 Dec; 113 Pt 24():4451-61. PubMed ID: 11082039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domain exchangeability between the multidrug transporter (MDR1) and phosphatidylcholine flippase (MDR2).
    Zhou Y; Gottesman MM; Pastan I
    Mol Pharmacol; 1999 Nov; 56(5):997-1004. PubMed ID: 10531406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation.
    Ozvegy C; Váradi A; Sarkadi B
    J Biol Chem; 2002 Dec; 277(50):47980-90. PubMed ID: 12374800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent modification of human P-glycoprotein mutants containing a single cysteine in either nucleotide-binding fold abolishes drug-stimulated ATPase activity.
    Loo TW; Clarke DM
    J Biol Chem; 1995 Sep; 270(39):22957-61. PubMed ID: 7559432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both ATP sites of human P-glycoprotein are essential but not symmetric.
    Hrycyna CA; Ramachandra M; Germann UA; Cheng PW; Pastan I; Gottesman MM
    Biochemistry; 1999 Oct; 38(42):13887-99. PubMed ID: 10529234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genes encoding multiple drug resistance-like proteins in Aspergillus fumigatus and Aspergillus flavus.
    Tobin MB; Peery RB; Skatrud PL
    Gene; 1997 Oct; 200(1-2):11-23. PubMed ID: 9373135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
    De Rosa MF; Ackerley C; Wang B; Ito S; Clarke DM; Lingwood C
    J Biol Chem; 2008 Feb; 283(8):4501-11. PubMed ID: 18003606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new structural model for P-glycoprotein.
    Jones PM; George AM
    J Membr Biol; 1998 Nov; 166(2):133-47. PubMed ID: 9841738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-stimulated nucleotide trapping in the human multidrug transporter MDR1. Cooperation of the nucleotide binding domains.
    Szabó K; Welker E; Bakos ; Müller M; Roninson I; Váradi A; Sarkadi B
    J Biol Chem; 1998 Apr; 273(17):10132-8. PubMed ID: 9553060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generating symmetry in the asymmetric ATP-binding cassette (ABC) transporter Pdr5 from Saccharomyces cerevisiae.
    Gupta RP; Kueppers P; Hanekop N; Schmitt L
    J Biol Chem; 2014 May; 289(22):15272-9. PubMed ID: 24733388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the nucleotide-binding sites of P-glycoprotein that affect substrate specificity modulate substrate-induced adenosine triphosphatase activity.
    Beaudet L; Urbatsch IL; Gros P
    Biochemistry; 1998 Jun; 37(25):9073-82. PubMed ID: 9636053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.